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The objective of this study was to investigate bacterial resistance trends, infection sites and
the relationship between resistance and admittance to the intensive care unit (ICU). A total
of  53,316 bacteria identiﬁed between 1999 and 2008 were evaluated. Multidrug resistance
was  characterized when gram-negative bacilli (GNB) presented resistance to two or more
classes  of antibiotics. Gram-positive cocci (CPC) were assessed for resistance to penicillin,
oxacillin  and vancomycin. GNB were the most common (66.1%) isolate. There was a 3.7-fold
overall  increase in multidrug resistant GNB over the study period; Acinetobacter baumanii
and  Staphylococcus aureus were the most prevalent. Highest increases were  recorded for Kleb-
siella  pneumoniae (14.6-fold) and enterococci (73-fold). The resistance rates for GNB and GPC
were  36% and 51.7%, respectively. Most multidrug resistant GNB and GPC were  recoveredfrom  ICU patients (p-value < 0.001). Vancomycin-resistant enterococci were isolated during
this  decade with an increase of 18.7% by 2008. These data conﬁrm the worldwide trend in
multidrug  bacterial resistance.
most  common hospital-acquired pathogens. In the 1980s
© 2013 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDThe introduction of antibiotics in the 1930s allowed for a
change  in hospital care and the development of progres-
sively more  sophisticated procedures. However, in the 1950s
and  1960s there was  a pandemic of nosocomial infections
caused by Staphylococcus aureus. In the 1970s, gram-negative
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oxacillin-resistant staphylococci became a major concern and
the  importance of enterococci increased. During the 1990s,
antibiotic-resistant organisms became even more  important
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n the hospitals environment, particularly in intensive care
nits  (ICUs), which were  at the epicenter of Multidrug Resis-
ant  bacteria (MDR). This further undermined the survival of
atients  and allowed the spread of resistant pathogens to
ther  hospital units, to other healthcare services and to the
ommunity  at large.
Resistance  to antibiotics is considered a major threat
o  health by the World Health Organization. The European
ommunity reported 25,000 deaths related to infection by
DR  at a cost of 1.5 billion Euros.1,2 Therefore, the devel-
pment of new antibiotics has become of major global
oncern.
According to the literature, variations in resistance rates
nd  mechanisms underlying the characteristics of each geo-
raphical  region and each institution make knowledge of local
pidemiology essential. The aim of this study was to report the
ain  multidrug resistant agents, trends, origins/types of spec-
men  and the relationship between the nature of infection and
dmittance  to the ICU.
This study was  conducted in a teaching hospital afﬁliated
o  a Medical School; 80% of patients are under the auspices of
he  National Health Service. It is a 716-bed (89 in ICUs) general
ospital.  Highly complex procedures are carried out including
rgan  transplants (bone marrow, liver, kidney, heart, etc.) and
nfant  heart surgery.
All  hospital GNB and gram-positive cocci (GPC) were iso-
ated  during the period from January 1st 1999 to December
1st  2008 and were identiﬁed at the Microbiology Laboratory
atabase of the institution. Isolates were not distinguished
rom colonization or infection. To avoid duplication of results,
nly  the ﬁrst sample from each source in a given month
as  considered, except for catheters related samples. Iso-
ates  whose antibiogram yielded resistant or intermediate
esults were  deemed resistant. GNB were  deﬁned as MDR
hen  there were  resistance to two or more  distinct classes
f  antibiotics; all antibiotics of a particular class should have
ielded  intermediate or resistant results. The following classes
f  antibiotics were  tested: aminoglycosides, quinolones,
eta-lactams (cephalosporins, beta-lactamase inhibitors, car-
apenems)  and polymyxin B. Beta lactam antibiotics were
valuated  individually.
Resistance was  deﬁned for speciﬁc GPC: oxacillin-
esistant Staphylococcus aureus, oxacillin-resistant coagulase-
egative  staphylococci, penicillin-resistant streptococci, and
ancomycin-resistant enterococci were  characterized on the
rounds  of antibiogram results. The laboratory routinely uses
he  Kirby–Bauer antibiotic test. Variables that were evaluated
ncluded  microbial species, origin/type of specimen and the
ospital  unit where the patient was  hospitalized (ICU and
on-ICU).
During  the study period, 53,316 nosocomial bacteria were
solated,  35,250 of which (66.1%) were  GNB. The 12 most com-
on  GNB, totaling 29,824 (84.6%), were selected to evaluate
esistance; the remainder were  of no apparent microbiologi-
al  or epidemiological interest according to the more  prevalent
osocomial agents. Overall 10,732 (36%) were  characterized as
DR.
GPC accounted for 18,066 (33.9%) of hospital-acquired
acteria; 17,575 (97.3%) were  selected to evaluate resistance
s  the remaining GPC had either incomplete antibiograms or3;1 7(4):480–482  481
lacked  apparent microbiological or epidemiological interest.
Of  these, 9086 (51.7%) were characterized as resistant.
Of  the MDR GNB (10,732), the most frequent ﬁve bacteria
(9416  – 87.7%) were chosen for analysis. These included Acine-
tobacter  baumanii (3410 – 31.8%), Pseudomonas aeruginosa (2700 –
25.1%), Klebsiella pneumoniae (2173 – 20.2%), Escherichia coli (577
–  5.4%) and Citrobacter freundii (556 – 5.2%). Resistant GPC were
evaluated  in four groups, as follows: S. aureus (8345 – 47.5%),
coagulase-negative staphylococci (4986 – 28.4%), enterococci
(2571  – 15.6%) and streptococci (1673 – 9.5%).
MDR GNB and resistant GPC isolates were recovered from
respiratory tract (25.4% and 11.3%), urinary tract (30% and
5%),  blood, and catheters (23.8% and 50.5%), ﬂuids and non-
respiratory  tract secretions (17.4% and 27.4%) and other
specimens (3.4% and 5.8%).
A total of 6314 MDR GNB were  isolated from ICU patients
and  3102 from non-ICU patients (p-value < 0.001). Moreover,
2438  resistant GPC and 4552 sensitive GPC were  isolated from
ICU  patients compared to 6051 and 4534, respectively from
non-ICU  patients (p-value < 0.001).
In  1999, 332 MDR GNB were  identiﬁed and while 1221 MDR
GNB  were isolated in 2008. Details of the changes in numbers
and  percentages of the isolates are shown in Table 1.
It  is important to remember that some of these isolates
may  be due to contamination of the collected specimens or
represent  colonization or pre-existent infections of patients.
The  quantiﬁcation and correlation of these isolates were  not
beyond  the scope of the current study.
During the study period the frequency of nosocomial GNB
was  twofold higher than that of GPC which highlights the
importance of these agents. The total number of cases of MDR
GNB  per year (Table 1) increased 3.7-fold during one decade.
The  three most common MDR  GNB, Acinetobacter baumannii,
Pseudomonas aeruginosa and klebsiella pneumoniae, accounted
for  77.1% of all GNB with 4.8-fold, 1.5-fold, and 14.6-fold
increases, respectively over the study period; this underlines
the  global trend in multiresistance.3,4 The frequencies of the
isolates  related to the different wards and types of specimens
were  similar. The number of MDR GNB isolates was  statisti-
cally  higher in the ICU compared to other units of the hospital,
a  fact that has been widely reported in the literature.5
S. aureus was the most prevalent resistant GPC accounting
for  almost half (47.5%) of the total number of cases, as was
reported  by The Surveillance Network (TSN), a network of 300
laboratories  in the USA.6 The number of cases of both S. aureus
and  streptococci remained relatively stable over the decade.
However, there was  a 1.7-fold increase in coagulase-negative
staphylococci during the study period. Table 1 shows the dra-
matic  increase in resistant enterococci during the decade of
the  study, with a 73-fold increase and a peak of 147 iso-
lates.  According to the records the ﬁrst vancomycin-resistant
enterococci isolated in this hospital was  in urine in August
1998,  10 years after the ﬁrst vancomycin-resistant enterococci
had  been identiﬁed in the world and two years after the ﬁrst
isolate  identiﬁed in Brazil.7 For samples originating from the
respiratory  and urinary tracts there was  a smaller proportion
of  resistant GPC compared to MDR  GNB. The opposite was  seen
for  blood and catheters. The high rate of resistant GPC iso-
lates  (50.5%) from blood and catheters was  mainly related to
coagulase-negative staphylococci, a fact that has already been
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Table 1 – Total multidrug resistant gram-negative bacilli (GNB) and most common species and percentage of resistant
gram-positive cocci (GPC) from January 1st 1999 to December 31st 2008 in a tertiary university hospital.
Agent Years
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Total MR GNB 332 652 663 768 798 1174 1364 1251 1193 1221
Acinetobacter baumannii 111  228 242 261 222 338 538 507 426 537
Pseudomonas aeruginosa 142  108 238 246 242 283 382 385 302 211
klebsiella pneumoniae 27 59 90 135 198 365 304 248 353 394
GPC
Oxa-R S. aureus 318 546 625 605 382 268 459 465 475 363
(%) 57.3 62.5 57.3 60.9 45.2 47.1 58.1 55.4 51.3 51.3
Oxa-R ECN 261 317 261 189 238 418 621 458 512 446
(%) 59.3 67.3 73.9 74.4 63 71.1 85.7 82.5 78.2 78.7
V-R enterococcus 1 2 0 0 2 4 19 24 147 73
(%) 1 1.3 0 0 0.9 1.4 5.8 8.1 34.2 19.6
P-R streptococcus 37 54 83 83 61 51 47 22 27 32
(%) 33 26.7 32.1 37.7 27.4 26.3 35.1 19.6 27.6 26.9
MR, multidrug resistant; GNB, gram-negative bacilli; GPC, gram-positive cocci; Oxa-R, oxacillin-resistant; P-R, penicillin-resistant; V-R,
r
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8.  Góngora-Rubio F, Pignatari AC, Costa LM, Bortolloto VI,vancomycin-resistant.
reported in the literature.8 Resistant GPC are equally found in
the ICU and in other units of the hospital (4552/4616), in con-
trast  to antibiotic-sensitive GPC (ICU 2348 and non-ICU 6051)
for  which there was  a signiﬁcant difference (p-value < 0.001)
underscoring the importance of these agents in the ICU.
Although  the overall rate of resistant GPC (52.8%) was
higher  than the MDR  GNB (36%), the major concern today is the
lack  of therapeutic options for the treatment of the latter.1 This
work  did not analyze the occurrence of resistance to speciﬁc
antibiotics according to GNB species. The results of this work
illustrate  that S. aureus and streptococci resistance remained
relatively stable over the decade (Table 1). However, coagulase-
negative  staphylococci resistance increased by 19.3% during
the  period, besides presenting a higher level of resistance than
S.  aureus. There was  a real emergency with respect to resis-
tance  of enterococci: starting at 1%, the annual resistance
increased to 34.2% and then dropped back to 19.6% in 2008
giving  a total increase over the period of 18.7%.
In conclusion, over the decade evaluated in this study there
was  a high prevalence of MDR  GNB, in particular Acinetobacter
baumannii and klebsiella pneumoniae. There was also a grad-
ual  increase in the multidrug resistant GNB. S. aureus became
the  most prevalent GPC and vancomycin-resistant entero-
cocci  have emerged during this decade. These two classes
of  bacteria were  signiﬁcantly more  frequently isolated in
the  ICU. For this institution, the emergence of vancomycin-
resistant enterococci was  the main concern in the evaluated
decade. Measures to prevent and control the dissemination
of  infectious agents and optimization of antibiotic use must
be  considered priorities. Future studies speciﬁcally evaluating
molecular microbiology of MDR  GNB species and enterococci,
the  site of infections, analysis of hospital units, the evolu-
tion  of antibiotic resistant MDR  GNB and consumption of
antimicrobials are needed. Finally, this synopsis conﬁrms the
trend  in multidrug resistance in a single center over the past
decade  as a reﬂection of a phenomenon that may  occur world-
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